Abstract: A method of determining identity, purity and/or potency of chondrocytes in vitro includes a) isolating and, optionally, culturing chondrocytes from a biological sample, and b) determining gene expression of at least one marker in the chondrocytes selected from the group consisting of FLT-1, IL-1beta, BSP-2, and type I collagen.
Type:
Grant
Filed:
July 27, 2011
Date of Patent:
July 14, 2015
Assignee:
TETEC Tissue Engineering Technologies
Inventors:
Juergen Mollenhauer, Christoph Gaissmaier